Last 7 days
-3.5%
Last 30 days
-1.5%
Last 90 days
-18.9%
Trailing 12 Months
-36.7%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
PSA | 50.3B | 4.3B | -0.67% | -7.84% | 11.56 | 11.69 | 18.80% | 113.99% |
DLR | 28.8B | 4.9B | 1.25% | -24.57% | 77.2 | 5.88 | 9.82% | -73.28% |
EQR | 22.6B | 2.0B | -1.01% | -20.50% | 24.61 | 11.43 | -20.93% | -31.79% |
ARE | 19.1B | 2.7B | -6.88% | -30.41% | 25.48 | 7.14 | 18.91% | 81.13% |
KIM | 13.2B | 1.7B | -4.07% | -25.83% | 104.43 | 7.61 | 15.49% | -81.09% |
MID-CAP | ||||||||
FRT | 7.1B | 1.1B | -8.04% | -21.25% | 18.25 | 6.51 | 10.19% | 46.60% |
KRG | 4.3B | 814.4M | -2.26% | -4.29% | 465.69 | 5.23 | 63.41% | 107.43% |
VNO | 2.6B | 1.8B | -10.72% | -60.29% | -6.95 | 1.42 | 9.23% | -286.27% |
MAC | 2.0B | 857.9M | -0.32% | -17.87% | -23.05 | 2.35 | -1.75% | -315.36% |
SMALL-CAP | ||||||||
SKT | 2.1B | 421.5M | 12.31% | 19.76% | 23.93 | 5.05 | 1.34% | 437.34% |
SLG | 1.4B | 862.4M | -3.29% | -61.71% | -11.46 | 1.67 | 7.01% | -127.00% |
AIV | 1.2B | 184.6M | 6.32% | 29.74% | 12.67 | 6.33 | 2.55% | 1950.56% |
PGRE | 923.1M | 745.2M | 2.66% | -52.44% | -24.26 | 1.24 | 2.17% | -183.81% |
Income Statement (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Revenue | 1.3% | 2,088 | 2,061 | 2,020 | 1,981 | 1,939 |
S&GA Expenses | 0.5% | 132 | 131 | 99.00 | 98.00 | 97.00 |
EBITDA | -0.2% | 1,391 | 1,393 | 1,091 | 1,177 | - |
EBITDA Margin | -2.2% | 0.67* | 0.69* | 0.55* | 0.61* | - |
Earnings Before Taxes | 11.7% | 566 | 507 | 523 | 226 | 324 |
EBT Margin | -5.0% | 0.25* | 0.26* | 0.11* | 0.17* | - |
Interest Expenses | 6.0% | 183 | 173 | 160 | 152 | 149 |
Net Income | 9.5% | 548 | 500 | 523 | 223 | 431 |
Net Income Margin | -6.2% | 0.24* | 0.26* | 0.11* | 0.22* | - |
Free Cahsflow | -1.8% | 900 | 917 | 885 | 867 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Assets | -1.1% | 15,602 | 15,771 | 15,662 | 15,318 | 15,287 |
Cash Equivalents | -17.8% | 59.00 | 72.00 | 112 | 73.00 | 89.00 |
Liabilities | -1.2% | 8,379 | 8,483 | 8,536 | 8,362 | 8,242 |
Long Term Debt | 2.1% | 6,591 | 6,454 | 6,336 | - | - |
Shareholder's Equity | -0.7% | 6,610 | 6,655 | 6,467 | 6,840 | 6,948 |
Additional Paid-In Capital | 0.1% | 10,360 | 10,350 | 10,015 | 10,074 | 10,085 |
Shares Outstanding | 0.1% | 547 | 547 | 538 | 540 | 539 |
Minority Interest | 0.0% | 528 | 528 | 532 | 535 | 539 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Cashflow From Operations | -2.3% | 880 | 900 | 917 | 885 | 867 |
Share Based Compensation | -5.4% | 25.00 | 26.00 | 19.00 | 19.00 | 19.00 |
Cashflow From Investing | 34.5% | -574 | -876 | -1,250 | -1,642 | -482 |
Cashflow From Financing | -190.0% | -337 | -116 | 234 | 649 | -382 |
Dividend Payments | 0.2% | 650 | 648 | 649 | 649 | 649 |
Buy Backs | -7.2% | 63.00 | 68.00 | 68.00 | 12.00 | 12.00 |
45.8%
38.5%
18.5%
Y-axis is the maximum loss one would have experienced if Healthpeak Properties was unfortunately bought at previous high price.
-2.9%
-0.3%
2.6%
4.9%
FIve years rolling returns for Healthpeak Properties.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-05-23 | Front Row Advisors LLC | unchanged | - | -1,000 | - | -% |
2023-05-23 | Toroso Investments, LLC | added | 100 | 312,000 | 724,000 | 0.01% |
2023-05-23 | Brookfield Corp /ON/ | added | 4.65 | -7,031,900 | 77,758,100 | 0.30% |
2023-05-22 | FDx Advisors, Inc. | unchanged | - | - | 2,208,000 | 0.10% |
2023-05-22 | PUTNAM INVESTMENTS LLC | new | - | 10,564,600 | 10,564,600 | 0.02% |
2023-05-22 | AMERIPRISE FINANCIAL INC | added | 59.23 | 5,952,030 | 20,986,000 | 0.01% |
2023-05-22 | Arete Wealth Advisors, LLC | new | - | 269,000 | 269,000 | 0.02% |
2023-05-22 | Raleigh Capital Management Inc. | added | 2.78 | -25,892 | 234,796 | 0.12% |
2023-05-18 | SkyView Investment Advisors, LLC | new | - | - | - | -% |
2023-05-18 | Harvest Portfolios Group Inc. | added | 13.09 | -3,478 | 385,859 | 0.02% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | cohen & steers, inc. | 2.86% | 15,386,796 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 16.37% | 87,991,432 | SC 13G/A | |
Feb 03, 2023 | state street corp | 7.31% | 39,270,414 | SC 13G/A | |
Jan 26, 2023 | blackrock inc. | 11.1% | 59,435,809 | SC 13G/A | |
Jan 20, 2023 | blackrock inc. | 11.1% | 59,435,809 | SC 13G/A | |
Sep 12, 2022 | cohen & steers, inc. | 7.51% | 40,509,274 | SC 13G/A | |
Feb 14, 2022 | cohen & steers, inc. | 13.07% | 70,462,139 | SC 13G/A | |
Feb 11, 2022 | state street corp | 6.60% | 35,583,315 | SC 13G/A | |
Feb 10, 2022 | vanguard group inc | 15.96% | 86,061,246 | SC 13G/A | |
Jan 27, 2022 | blackrock inc. | 10.6% | 57,115,834 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 9.75 - | 11.29 - | 20.51 - | 29.52 - | 35.06 - |
Current Inflation | 9.39 - | 10.82 - | 18.52 - | 26.13 - | 30.74 - |
Very High Inflation | 8.94 - | 10.21 - | 16.17 - | 22.19 - | 25.77 - |
Date Filed | Form Type | Document | |
---|---|---|---|
May 10, 2023 | 8-K | Current Report | |
May 02, 2023 | 424B5 | Prospectus Filed | |
May 02, 2023 | 8-K | Current Report | |
May 01, 2023 | FWP | Prospectus Filed | |
May 01, 2023 | 424B5 | Prospectus Filed | |
May 01, 2023 | 4 | Insider Trading | |
May 01, 2023 | 4 | Insider Trading | |
May 01, 2023 | 4 | Insider Trading | |
May 01, 2023 | 4 | Insider Trading | |
May 01, 2023 | 4 | Insider Trading |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-04-28 | Lewis Sara Grootwassink | acquired | - | - | 8,193 | - |
2023-04-28 | Cartwright Brian G. | acquired | - | - | 8,193 | - |
2023-04-28 | Griffin R Kent Jr | acquired | - | - | 8,193 | - |
2023-04-28 | GARVEY CHRISTINE | acquired | - | - | 8,193 | - |
2023-04-28 | Sandstrom Katherine M | acquired | - | - | 8,193 | - |
2023-04-28 | Connor James B. | acquired | - | - | 8,193 | - |
2023-04-28 | HENRY DAVID | acquired | - | - | 8,193 | - |
2023-03-17 | Klaritch Thomas | gifted | - | - | -7,100 | coo |
2023-03-15 | Lewis Sara Grootwassink | bought | 85,728 | 21.4322 | 4,000 | - |
2023-03-07 | Klaritch Thomas | bought | 35,203 | 23.206 | 1,517 | coo |
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2023 | Mar. 31, 2022 | |
Revenues [Abstract] | ||
Rental and related revenues | $ 392,431 | $ 370,150 |
Resident fees and services | 127,084 | 121,560 |
Interest income | 6,163 | 5,494 |
Income from direct financing leases | 0 | 1,168 |
Total revenues | 525,678 | 498,372 |
Costs and expenses: | ||
Interest expense | 47,963 | 37,586 |
Depreciation and amortization | 179,225 | 177,733 |
Operating | 223,088 | 207,247 |
General and administrative | 24,547 | 23,831 |
Transaction costs | 2,425 | 296 |
Impairments and loan loss reserves (recoveries), net | (2,213) | 132 |
Total costs and expenses | 475,035 | 446,825 |
Other income (expense): | ||
Gain (loss) on sales of real estate, net | 81,578 | 3,856 |
Other income (expense), net | 772 | 18,316 |
Total other income (expense), net | 82,350 | 22,172 |
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures | 132,993 | 73,719 |
Income tax benefit (expense) | (302) | (777) |
Equity income (loss) from unconsolidated joint ventures | 1,816 | 2,084 |
Income (loss) from continuing operations | 134,507 | 75,026 |
Income (loss) from discontinued operations | 0 | 317 |
Net income (loss) | 134,507 | 75,343 |
Noncontrolling interests’ share in continuing operations | (15,555) | (3,730) |
Net income (loss) attributable to Healthpeak Properties, Inc. | 118,952 | 71,613 |
Participating securities’ share in earnings | (1,254) | (1,976) |
Net income (loss) applicable to common shares | $ 117,698 | $ 69,637 |
Earnings Per Share [Abstract] | ||
Continuing operations (in dollars per share) | $ 0.22 | $ 0.13 |
Discontinued operations (in dollars per share) | 0 | 0.00 |
Net income (loss) applicable to common shares (in dollars per share) | 0.22 | 0.13 |
Diluted earnings (loss) per common share: | ||
Continuing operations (in dollars per share) | 0.22 | 0.13 |
Discontinued operations (in dollars per share) | 0 | 0.00 |
Net income (loss) applicable to common shares (in dollars per share) | $ 0.22 | $ 0.13 |
Weighted average shares outstanding: | ||
Basic (in shares) | 546,842 | 539,352 |
Diluted (in shares) | 547,110 | 539,586 |
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Real estate: | ||
Buildings and improvements | $ 12,889,290 | $ 12,784,078 |
Development costs and construction in progress | 819,810 | 760,355 |
Land | 2,674,942 | 2,667,188 |
Accumulated depreciation and amortization | (3,296,781) | (3,188,138) |
Net real estate | 13,087,261 | 13,023,483 |
Loans receivable, net of reserves of $6,152 and $8,280 | 243,149 | 374,832 |
Investments in and advances to unconsolidated joint ventures | 714,679 | 706,677 |
Accounts receivable, net of allowance of $2,413 and $2,399 | 57,705 | 53,436 |
Cash and cash equivalents | 59,235 | 72,032 |
Restricted cash | 57,990 | 54,802 |
Intangible assets, net | 391,956 | 418,061 |
Assets held for sale, net | 0 | 49,866 |
Right-of-use asset, net | 235,591 | 237,318 |
Other assets, net | 754,723 | 780,722 |
Total assets | 15,602,289 | 15,771,229 |
LIABILITIES AND EQUITY | ||
Bank line of credit and commercial paper | 556,000 | 995,606 |
Term loans | 496,168 | 495,957 |
Senior unsecured notes | 5,056,543 | 4,659,451 |
Mortgage debt | 345,167 | 346,599 |
Intangible liabilities, net | 149,604 | 156,193 |
Liabilities related to assets held for sale, net | 0 | 4,070 |
Lease liability | 207,734 | 208,515 |
Accounts payable, accrued liabilities, and other liabilities | 688,994 | 772,485 |
Deferred revenue | 878,444 | 844,076 |
Total liabilities | 8,378,654 | 8,482,952 |
Commitments and contingencies (Note 10) | ||
Redeemable noncontrolling interests | 85,902 | 105,679 |
Common stock, $1.00 par value: 750,000,000 shares authorized; 546,994,803 and 546,641,973 shares issued and outstanding | 546,995 | 546,642 |
Additional paid-in capital | 10,360,058 | 10,349,614 |
Cumulative dividends in excess of earnings | (4,316,038) | (4,269,689) |
Accumulated other comprehensive income (loss) | 18,721 | 28,134 |
Total stockholders’ equity | 6,609,736 | 6,654,701 |
Joint venture partners | 320,363 | 327,721 |
Non-managing member unitholders | 207,634 | 200,176 |
Total noncontrolling interests | 527,997 | 527,897 |
Total equity | 7,137,733 | 7,182,598 |
Total liabilities and equity | $ 15,602,289 | $ 15,771,229 |